Search Our Website:
menu

TOLEDO

25 South Huron Street

Toledo, OH 43604

DATE
TITLE
CONTRIBUTORS
SERVICES & INDUSTRIES
DEC 22 2025

U.S. House Passes Bill to Expedite Interstate Natural Gas Pipeline Permitting

ALAN M. SELTZER JOHN F. POVILAITIS SAMUEL P. BAYCER
ENERGY
DEC 12 2025

Clarifying Antitrust Requirements for NIL-Era Eligibility Challenges

ANDREW G. HOPE DAVID A. GURWIN JORDYNN E. JACKSON
ANTITRUST & TRADE REGULATION EDUCATION LITIGATION NAME, IMAGE, AND LIKENESS (NIL)
NOV 26 2025

The Future of College Sports in Flux: Big Ten’s Private Equity Deal Sparks Uncertainty

ANDREW G. HOPE DAVID A. GURWIN KELLEN M. CARLETON
EDUCATION LITIGATION NAME, IMAGE, AND LIKENESS (NIL)
OCT 29 2025

Ohio Court Expands NIL Rights to High School Athletes

ANDREW G. HOPE DAVID A. GURWIN JORDYNN E. JACKSON
EDUCATION LITIGATION NAME, IMAGE, AND LIKENESS (NIL)
OCT 15 2025

The PBM Effect: Regulatory and Market Implications for Life Sciences Companies and Healthcare Providers

DAE Y. LEE LUCAS W. MORGAN
HEALTHCARE LIFE SCIENCES PBM AUDIT DEFENSE & CONTRACT SERVICES
SEP 2 2025

Milking the Clock: Legal Challenges to the NCAA’s Five-Year Rule in the NIL Era

ANDREW G. HOPE DAVID A. GURWIN JORDYNN E. JACKSON
ANTITRUST & TRADE REGULATION LABOR & EMPLOYMENT LITIGATION NAME, IMAGE, AND LIKENESS (NIL)
AUG 27 2025

Alternative Power Plays:Community-level Decarbonization

ALAN M. SELTZER JOHN F. POVILAITIS
ENERGY RENEWABLES AND ALTERNATIVE ENERGY
AUG 26 2025

Rapid Rundown: Latest on Marijuana Rescheduling from an FDA Perspective

DANIEL P. MCGEE NATALIE C. OEHLERS
CANNABIS
AUG 25 2025

Delta-8 Dilemma: FDA Issues Another Warning Letter

DANIEL P. MCGEE NATALIE C. OEHLERS
CANNABIS FDA & BIOTECHNOLOGY
AUG 25 2025

Legal Updates on Arkansas Law Banning PBMs From Owning Affiliated Pharmacies

CAITLIN M. COLLINS LUCAS W. MORGAN
FDA & BIOTECHNOLOGY PBM AUDIT DEFENSE & CONTRACT SERVICES
AUG 15 2025

Decoding the Tax Implications of the One Big, Beautiful Bill Act for Companies & Investors

CARL F. STAIGER JARED R. JOHNSON LISA M. STARCZEWSKI PHILIP R. HIRSCHFELD SAHEL AHYAIE ASSAR
BUSINESS TAX ENERGY INTERNATIONAL TAX OPPORTUNITY ZONES TAX
AUG 13 2025

Alternative Power Plays: The Evolution of Wholesale Electricity

ALAN M. SELTZER JOHN F. POVILAITIS
COMBINED HEAT & POWER (CHP) ENERGY RENEWABLES AND ALTERNATIVE ENERGY
AUG 5 2025

Major Update on GLP-1 Litigation involving Compounding Pharmacies

DAE Y. LEE LUCAS W. MORGAN NATALIE P. CROW
FDA & BIOTECHNOLOGY PBM AUDIT DEFENSE & CONTRACT SERVICES
JUL 31 2025

Clear the Air: FDA Cracks Down on Illegal Vapes Entering the U.S.

ALLISON L. BORGATTI DANIEL P. MCGEE GEORGE M. KARAVETSOS NATALIE C. OEHLERS
FDA & BIOTECHNOLOGY LIFE SCIENCES LITIGATION WHITE COLLAR DEFENSE, COMPLIANCE & INVESTIGATIONS
JUL 25 2025

From Eligibility to Enforcement: How Law and Policy Are Shaping College Athletics

ANDREW G. HOPE DAVID A. GURWIN JORDYNN E. JACKSON
ANTITRUST & TRADE REGULATION LABOR & EMPLOYMENT LITIGATION NAME, IMAGE, AND LIKENESS (NIL) TITLE IX
JUL 22 2025

The 340B Drug Pricing Program: Navigating Challenges in Healthcare Access

CAITLIN M. COLLINS DAE Y. LEE LUCAS W. MORGAN
FDA & BIOTECHNOLOGY PBM AUDIT DEFENSE & CONTRACT SERVICES
JUL 22 2025

New Rules to Impact Texas Pharmacies

CAITLIN M. COLLINS DAE Y. LEE LUCAS W. MORGAN
FDA & BIOTECHNOLOGY PBM AUDIT DEFENSE & CONTRACT SERVICES
JUL 15 2025

No More Baby Steps: FDA Call to Action to Enhance Recall Communications For Infant Formula, Baby Foods, and Foods Intended for Children

ALLISON L. BORGATTI GEORGE M. KARAVETSOS NATALIE C. OEHLERS
FDA & BIOTECHNOLOGY LIFE SCIENCES WHITE COLLAR DEFENSE, COMPLIANCE & INVESTIGATIONS
JUL 3 2025

The “One, Big, Beautiful Bill” Becomes Law: High-Level Summary of Renewable Energy Tax Provisions

CARL F. STAIGER EDWARD G. HILD
ENERGY GOVERNMENT RELATIONS & PUBLIC POLICY TAX
JUL 2 2025

Alternative Power Plays: Renewable Hydrogen Energy with the First Public Hydrogen Authority

ALAN M. SELTZER JOHN F. POVILAITIS
ENERGY HYDROGEN ENERGY RENEWABLES AND ALTERNATIVE ENERGY
JUN 27 2025

Ohio Board of Pharmacy Prescribes New Rules for Ohio Pharmacies

LUCAS W. MORGAN
FDA & BIOTECHNOLOGY PBM AUDIT DEFENSE & CONTRACT SERVICES
JUN 24 2025

Color Us Intrigued: Staying Ahead of FDA’s Regulatory Changes for Colors

BARBARA A. BINZAK BLUMENFELD, PH.D. NATALIE C. OEHLERS NATALIE P. CROW
FDA & BIOTECHNOLOGY LIFE SCIENCES
JUN 23 2025

Seven County Infrastructure Coalition et al. v. Eagle County, Colorado et al.: An Important U.S. Supreme Court Decision on the Scope of Judicial Review of NEPA Environmental Impact Statements

AMANDA L. WETZEL JAMES O'TOOLE, JR.
ENERGY ENVIRONMENTAL LITIGATION
JUN 20 2025

Paving a New Path: FDA Rolls Out New Incentive for Drug Developers

MICHAEL P. STRAZZELLA NATALIE C. OEHLERS
FDA & BIOTECHNOLOGY GOVERNMENT RELATIONS & PUBLIC POLICY LIFE SCIENCES
JUN 18 2025

Alternative Power Plays: Scalable and Affordable Green Hydrogen with Grimes Carbon Tech

ALAN M. SELTZER JOHN F. POVILAITIS
ENERGY HYDROGEN ENERGY RENEWABLES AND ALTERNATIVE ENERGY
JUN 13 2025

Ames v. Ohio : Supreme Court Upholds Uniformity in Title VII Discrimination Claims

ANDREW T. SIMMONS GEORGE C. MORRISON JAIME S. TUITE JOSEPH E. ABBOUD
LABOR & EMPLOYMENT
JUN 12 2025

State Board of Pharmacy: Ohio GLP-1 Compounders Be Vigilant

CAITLIN M. COLLINS DAE Y. LEE LUCAS W. MORGAN
FDA & BIOTECHNOLOGY PBM AUDIT DEFENSE & CONTRACT SERVICES
MAY 28 2025

State Importation Revamped: FDA Announces Enhancements to State Importation for Eligible Prescription Drugs

ALLISON L. BORGATTI BARBARA A. BINZAK BLUMENFELD, PH.D. GEORGE M. KARAVETSOS NATALIE C. OEHLERS NATALIE P. CROW
FDA & BIOTECHNOLOGY LITIGATION WHITE COLLAR DEFENSE, COMPLIANCE & INVESTIGATIONS
MAY 27 2025

Patent Predicament: FTC Revives Challenges to Over 200 Patent Listings

BARBARA A. BINZAK BLUMENFELD, PH.D. CARRIE G. AMEZCUA NATALIE C. OEHLERS
ANTITRUST & TRADE REGULATION FDA & BIOTECHNOLOGY
MAY 22 2025

The “One, Big, Beautiful Bill” - Summary of Renewable Energy Tax Provisions

CARL F. STAIGER EDWARD G. HILD
ENERGY GOVERNMENT RELATIONS & PUBLIC POLICY TAX
MAY 21 2025

Alternative Power Plays: Solving the Power Demand Challenge with Dynamic Line Rating Technology

ALAN M. SELTZER JOHN F. POVILAITIS
RENEWABLES AND ALTERNATIVE ENERGY
MAY 21 2025

Formula for Change: FDA Open the Door for Input on Nutrient Requirements for Infant Formula

ALLISON L. BORGATTI GEORGE M. KARAVETSOS NATALIE C. OEHLERS NATALIE P. CROW
FDA & BIOTECHNOLOGY LIFE SCIENCES WHITE COLLAR DEFENSE, COMPLIANCE & INVESTIGATIONS
MAY 15 2025

Pharmacies on Alert: Gilead Reports Pharmacies to State Boards Over Counterfeit Drug Purchases

DAE Y. LEE LUCAS W. MORGAN
FDA & BIOTECHNOLOGY PBM AUDIT DEFENSE & CONTRACT SERVICES
MAY 15 2025

Tianeptine: The War Rages On

ALLISON L. BORGATTI GEORGE M. KARAVETSOS NATALIE C. OEHLERS
FDA & BIOTECHNOLOGY LITIGATION WHITE COLLAR DEFENSE, COMPLIANCE & INVESTIGATIONS
MAY 14 2025

Tirzepatide Ruling: Implications for Compounders in an Evolving Legal Landscape

DAE Y. LEE LUCAS W. MORGAN NATALIE P. CROW
FDA & BIOTECHNOLOGY PBM AUDIT DEFENSE & CONTRACT SERVICES
MAY 7 2025

Alternative Power Plays: How Topology Optimization Improves the Grid

ALAN M. SELTZER JOHN F. POVILAITIS
ENERGY RENEWABLES AND ALTERNATIVE ENERGY
MAY 1 2025

Mixed Messages? New DEI Executive Order Seeks to Eliminate Disparate-Impact Theory

AMANDA M. SCARPO CHRISTOPHER J. DALTON JAIME S. TUITE
GOVERNMENT RELATIONS & PUBLIC POLICY LABOR & EMPLOYMENT
APR 25 2025

GLP-1 Litigation Escalates: What Pharmacies and Telemedicine Providers Need to Know

DAE Y. LEE LUCAS W. MORGAN
FDA & BIOTECHNOLOGY PBM AUDIT DEFENSE & CONTRACT SERVICES
APR 23 2025

Alternative Power Plays: The Future of Construction with Low-carbon Cement

ALAN M. SELTZER JOHN F. POVILAITIS
ENERGY RENEWABLES AND ALTERNATIVE ENERGY
APR 16 2025

Alternative Power Plays: U.S. Energy Outlook Under Trump 2.0

ALAN M. SELTZER EDWARD G. HILD JOHN F. POVILAITIS
ENERGY RENEWABLES AND ALTERNATIVE ENERGY
APR 2 2025

Alternative Power Plays: The Future of Long-duration Energy Storage with Hydrostor

ALAN M. SELTZER JOHN F. POVILAITIS
ENERGY RENEWABLES AND ALTERNATIVE ENERGY
MAR 13 2025

Alternative Power Plays: The U.S. Power Grid is Struggling – What Needs to Change Now

ALAN M. SELTZER JOHN F. POVILAITIS
ENERGY RENEWABLES AND ALTERNATIVE ENERGY
MAR 5 2025

Alternative Power Plays: Unlocking Rooftop Solar: Allume Energy’s Solution for Apartment Renters

ALAN M. SELTZER JOHN F. POVILAITIS
ENERGY RENEWABLES AND ALTERNATIVE ENERGY SOLAR ENERGY
FEB 19 2025

Alternative Power Plays: Climate Leadership in Pennsylvania: A Conversation with PA Rep. Greg Vitali

ALAN M. SELTZER ELIZABETH A. ROSENTEL
ENERGY GOVERNMENT RELATIONS & PUBLIC POLICY
FEB 3 2025

The 2024 EPA PFAS Regulations, EPA PFAS Enforcement Priorities, and Reopener Risks

ALEX M. PEARLSTEIN AMANDA L. WETZEL JAMES O'TOOLE, JR. LOUIS M. DESTEFANO
ENVIRONMENTAL
JAN 29 2025

FDA Reopens Door for Flavored Cigars and Menthol Cigarettes

DANIEL P. MCGEE NATALIE C. OEHLERS NATALIE P. CROW
FDA & BIOTECHNOLOGY LIFE SCIENCES
JAN 24 2025

FDA Grants Marketing Order for ZYN Nicotine Pouches

DANIEL P. MCGEE NATALIE C. OEHLERS
FDA & BIOTECHNOLOGY LIFE SCIENCES
JAN 15 2025

4 Potential FDA Drug Approvals to Watch in 2025

BARBARA A. BINZAK BLUMENFELD, PH.D. NATALIE C. OEHLERS NATALIE P. CROW TINA HU-RODGERS
FDA & BIOTECHNOLOGY LIFE SCIENCES
JAN 10 2025

Newly Issued Final Regulations for Clean Hydrogen: Key Takeaways

ALAN M. SELTZER CARL F. STAIGER JAMES O'TOOLE, JR. JOHN F. POVILAITIS SEAN W. MORAN
ENERGY TAX
JAN 3 2025

Fifth Circuit Invalidates Nasdaq Diversity Rules – What Public Companies Should Know

BRIAN S. NORTH BRIAN S. NOVOSEL JENNIFER R. MINTER STANLEY A. MARCINIAK, III
CORPORATE SECURITIES & SEC
JAN 2 2025

Glass Lewis & ISS Provide Policy Updates for 2025 Proxy Season: What This Means for You

ADAM G. WICKS JENNIFER R. MINTER KELLEN M. CARLETON STANLEY A. MARCINIAK, III
CORPORATE EXECUTIVE COMPENSATION SECURITIES & SEC